Dihydropyrimidine compound and application in medicine

The invention relates to a dihydropyrimidine compound and an application of the dihydropyrimidine compound as a medicine, particularly to an application of the dihydropyrimidine compound as a medicinefor treating and preventing hepatitis B, specifically to a compound represented by a general formula...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LI JING, YAN GUANGHUA, WANG MENG, LAI QINGYING, WANG HENG, CHEN YUNFU, LIU XINCHANG, REN QINGYUN, GUO LIANGHONG, LEI DOUXING, WANG XING'AN, ZHANG YINGJUN, YIN LIHUA
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LI JING
YAN GUANGHUA
WANG MENG
LAI QINGYING
WANG HENG
CHEN YUNFU
LIU XINCHANG
REN QINGYUN
GUO LIANGHONG
LEI DOUXING
WANG XING'AN
ZHANG YINGJUN
YIN LIHUA
description The invention relates to a dihydropyrimidine compound and an application of the dihydropyrimidine compound as a medicine, particularly to an application of the dihydropyrimidine compound as a medicinefor treating and preventing hepatitis B, specifically to a compound represented by a general formula (I) or (Ia) or a stereoisomer, a tautomer, a nitrogen oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, wherein each variable is defined in the specification. The invention also relates to application of the compound represented by the general formula (I) or(Ia) or the stereoisomer, tautomer, nitrogen oxide, solvate, metabolite and pharmaceutically acceptable salt thereof as a medicine, particularly to application of the compound as a medicine for treating and preventing hepatitis B. 本发明涉及一种二氢嘧啶类化合物及其作为药物的应用,尤其是作为治疗和预防乙型肝炎的药物的应用。具体地说,本发明涉及通式(I)或(Ia)所示的化合物或其立体异构体、互变异构体、氮氧化物、溶剂化物、代谢产物、药学上可接受的盐或它的前药,其中各变量如说明书所定义。本发明还涉及通式(I)或(Ia)所示的化合物或其立体异构体、互变异构体、氮氧化物、溶剂化物、代谢产物、药学上可接受的盐作为药物的用途,
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN111825676A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN111825676A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN111825676A3</originalsourceid><addsrcrecordid>eNrjZDBzycyoTCnKL6gsyszNTMnMS1VIzs8tyC_NS1FIBOGCgpzM5MSSzPw8hcw8hdzUlMxkoCIeBta0xJziVF4ozc2g6OYa4uyhm1qQH59aXJCYnJqXWhLv7GdoaGhhZGpmbuZoTIwaAOJgLhU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Dihydropyrimidine compound and application in medicine</title><source>esp@cenet</source><creator>LI JING ; YAN GUANGHUA ; WANG MENG ; LAI QINGYING ; WANG HENG ; CHEN YUNFU ; LIU XINCHANG ; REN QINGYUN ; GUO LIANGHONG ; LEI DOUXING ; WANG XING'AN ; ZHANG YINGJUN ; YIN LIHUA</creator><creatorcontrib>LI JING ; YAN GUANGHUA ; WANG MENG ; LAI QINGYING ; WANG HENG ; CHEN YUNFU ; LIU XINCHANG ; REN QINGYUN ; GUO LIANGHONG ; LEI DOUXING ; WANG XING'AN ; ZHANG YINGJUN ; YIN LIHUA</creatorcontrib><description>The invention relates to a dihydropyrimidine compound and an application of the dihydropyrimidine compound as a medicine, particularly to an application of the dihydropyrimidine compound as a medicinefor treating and preventing hepatitis B, specifically to a compound represented by a general formula (I) or (Ia) or a stereoisomer, a tautomer, a nitrogen oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, wherein each variable is defined in the specification. The invention also relates to application of the compound represented by the general formula (I) or(Ia) or the stereoisomer, tautomer, nitrogen oxide, solvate, metabolite and pharmaceutically acceptable salt thereof as a medicine, particularly to application of the compound as a medicine for treating and preventing hepatitis B. 本发明涉及一种二氢嘧啶类化合物及其作为药物的应用,尤其是作为治疗和预防乙型肝炎的药物的应用。具体地说,本发明涉及通式(I)或(Ia)所示的化合物或其立体异构体、互变异构体、氮氧化物、溶剂化物、代谢产物、药学上可接受的盐或它的前药,其中各变量如说明书所定义。本发明还涉及通式(I)或(Ia)所示的化合物或其立体异构体、互变异构体、氮氧化物、溶剂化物、代谢产物、药学上可接受的盐作为药物的用途,</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201027&amp;DB=EPODOC&amp;CC=CN&amp;NR=111825676A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201027&amp;DB=EPODOC&amp;CC=CN&amp;NR=111825676A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LI JING</creatorcontrib><creatorcontrib>YAN GUANGHUA</creatorcontrib><creatorcontrib>WANG MENG</creatorcontrib><creatorcontrib>LAI QINGYING</creatorcontrib><creatorcontrib>WANG HENG</creatorcontrib><creatorcontrib>CHEN YUNFU</creatorcontrib><creatorcontrib>LIU XINCHANG</creatorcontrib><creatorcontrib>REN QINGYUN</creatorcontrib><creatorcontrib>GUO LIANGHONG</creatorcontrib><creatorcontrib>LEI DOUXING</creatorcontrib><creatorcontrib>WANG XING'AN</creatorcontrib><creatorcontrib>ZHANG YINGJUN</creatorcontrib><creatorcontrib>YIN LIHUA</creatorcontrib><title>Dihydropyrimidine compound and application in medicine</title><description>The invention relates to a dihydropyrimidine compound and an application of the dihydropyrimidine compound as a medicine, particularly to an application of the dihydropyrimidine compound as a medicinefor treating and preventing hepatitis B, specifically to a compound represented by a general formula (I) or (Ia) or a stereoisomer, a tautomer, a nitrogen oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, wherein each variable is defined in the specification. The invention also relates to application of the compound represented by the general formula (I) or(Ia) or the stereoisomer, tautomer, nitrogen oxide, solvate, metabolite and pharmaceutically acceptable salt thereof as a medicine, particularly to application of the compound as a medicine for treating and preventing hepatitis B. 本发明涉及一种二氢嘧啶类化合物及其作为药物的应用,尤其是作为治疗和预防乙型肝炎的药物的应用。具体地说,本发明涉及通式(I)或(Ia)所示的化合物或其立体异构体、互变异构体、氮氧化物、溶剂化物、代谢产物、药学上可接受的盐或它的前药,其中各变量如说明书所定义。本发明还涉及通式(I)或(Ia)所示的化合物或其立体异构体、互变异构体、氮氧化物、溶剂化物、代谢产物、药学上可接受的盐作为药物的用途,</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBzycyoTCnKL6gsyszNTMnMS1VIzs8tyC_NS1FIBOGCgpzM5MSSzPw8hcw8hdzUlMxkoCIeBta0xJziVF4ozc2g6OYa4uyhm1qQH59aXJCYnJqXWhLv7GdoaGhhZGpmbuZoTIwaAOJgLhU</recordid><startdate>20201027</startdate><enddate>20201027</enddate><creator>LI JING</creator><creator>YAN GUANGHUA</creator><creator>WANG MENG</creator><creator>LAI QINGYING</creator><creator>WANG HENG</creator><creator>CHEN YUNFU</creator><creator>LIU XINCHANG</creator><creator>REN QINGYUN</creator><creator>GUO LIANGHONG</creator><creator>LEI DOUXING</creator><creator>WANG XING'AN</creator><creator>ZHANG YINGJUN</creator><creator>YIN LIHUA</creator><scope>EVB</scope></search><sort><creationdate>20201027</creationdate><title>Dihydropyrimidine compound and application in medicine</title><author>LI JING ; YAN GUANGHUA ; WANG MENG ; LAI QINGYING ; WANG HENG ; CHEN YUNFU ; LIU XINCHANG ; REN QINGYUN ; GUO LIANGHONG ; LEI DOUXING ; WANG XING'AN ; ZHANG YINGJUN ; YIN LIHUA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN111825676A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LI JING</creatorcontrib><creatorcontrib>YAN GUANGHUA</creatorcontrib><creatorcontrib>WANG MENG</creatorcontrib><creatorcontrib>LAI QINGYING</creatorcontrib><creatorcontrib>WANG HENG</creatorcontrib><creatorcontrib>CHEN YUNFU</creatorcontrib><creatorcontrib>LIU XINCHANG</creatorcontrib><creatorcontrib>REN QINGYUN</creatorcontrib><creatorcontrib>GUO LIANGHONG</creatorcontrib><creatorcontrib>LEI DOUXING</creatorcontrib><creatorcontrib>WANG XING'AN</creatorcontrib><creatorcontrib>ZHANG YINGJUN</creatorcontrib><creatorcontrib>YIN LIHUA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LI JING</au><au>YAN GUANGHUA</au><au>WANG MENG</au><au>LAI QINGYING</au><au>WANG HENG</au><au>CHEN YUNFU</au><au>LIU XINCHANG</au><au>REN QINGYUN</au><au>GUO LIANGHONG</au><au>LEI DOUXING</au><au>WANG XING'AN</au><au>ZHANG YINGJUN</au><au>YIN LIHUA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Dihydropyrimidine compound and application in medicine</title><date>2020-10-27</date><risdate>2020</risdate><abstract>The invention relates to a dihydropyrimidine compound and an application of the dihydropyrimidine compound as a medicine, particularly to an application of the dihydropyrimidine compound as a medicinefor treating and preventing hepatitis B, specifically to a compound represented by a general formula (I) or (Ia) or a stereoisomer, a tautomer, a nitrogen oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, wherein each variable is defined in the specification. The invention also relates to application of the compound represented by the general formula (I) or(Ia) or the stereoisomer, tautomer, nitrogen oxide, solvate, metabolite and pharmaceutically acceptable salt thereof as a medicine, particularly to application of the compound as a medicine for treating and preventing hepatitis B. 本发明涉及一种二氢嘧啶类化合物及其作为药物的应用,尤其是作为治疗和预防乙型肝炎的药物的应用。具体地说,本发明涉及通式(I)或(Ia)所示的化合物或其立体异构体、互变异构体、氮氧化物、溶剂化物、代谢产物、药学上可接受的盐或它的前药,其中各变量如说明书所定义。本发明还涉及通式(I)或(Ia)所示的化合物或其立体异构体、互变异构体、氮氧化物、溶剂化物、代谢产物、药学上可接受的盐作为药物的用途,</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN111825676A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Dihydropyrimidine compound and application in medicine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T03%3A31%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LI%20JING&rft.date=2020-10-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN111825676A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true